In addition, the HMGB3/hTERT signaling axis can be used as a new target for radiation resistance in cervical cancer, which provides new insights into the antiradiation mechanism of cervical cancer and suggests that targeting the HMGB3/hTERT signaling axis may be beneficial to patients with cervical cancer (Fang et al., 2020; Li et al., 2020). This evidence concerns the gene HMGB3 and cervical carcinoma.